Ortiz GM - Search Results

1

Dual pressure from antiretroviral therapy and cell-mediated immune response on the human immunodeficiency virus type 1 protease gene.

Karlsson AC, Deeks SG, Barbour JD, Heiken BD, Younger SR, Hoh R, Lane M, Sällberg M, Ortiz GM, Demarest JF, Liegler T, Grant RM, Martin JN, Nixon DF. Karlsson AC, et al. Among authors: ortiz gm. J Virol. 2003 Jun;77(12):6743-52. doi: 10.1128/jvi.77.12.6743-6752.2003. J Virol. 2003. PMID: 12767994 Free PMC article.

2

Residual viral replication during antiretroviral therapy boosts human immunodeficiency virus type 1-specific CD8+ T-cell responses in subjects treated early after infection.

Ortiz GM, Hu J, Goldwitz JA, Chandwani R, Larsson M, Bhardwaj N, Bonhoeffer S, Ramratnam B, Zhang L, Markowitz MM, Nixon DF. Ortiz GM, et al. J Virol. 2002 Jan;76(1):411-5. doi: 10.1128/jvi.76.1.411-415.2002. J Virol. 2002. PMID: 11739706 Free PMC article.

3

Emergence of drug-resistant HIV-1 variants in patients undergoing structured treatment interruptions.

Schweighardt B, Ortiz GM, Grant RM, Wellons M, Miralles GD, Kostrikis LG, Bartlett JA, Nixon DF. Schweighardt B, et al. Among authors: ortiz gm. AIDS. 2002 Nov 22;16(17):2342-4. doi: 10.1097/00002030-200211220-00018. AIDS. 2002. PMID: 12441810

4

Detection of T lymphocytes specific for human endogenous retrovirus K (HERV-K) in patients with seminoma.

Rakoff-Nahoum S, Kuebler PJ, Heymann JJ, E Sheehy M, Ortiz GM, S Ogg G, Barbour JD, Lenz J, Steinfeld AD, Nixon DF. Rakoff-Nahoum S, et al. Among authors: ortiz gm. AIDS Res Hum Retroviruses. 2006 Jan;22(1):52-6. doi: 10.1089/aid.2006.22.52. AIDS Res Hum Retroviruses. 2006. PMID: 16438646

5

Higher CD27+CD8+ T cells percentages during suppressive antiretroviral therapy predict greater subsequent CD4+ T cell recovery in treated HIV infection.

Seu L, Ortiz GM, Epling L, Sinclair E, Swainson LA, Bajpai UD, Huang Y, Deeks SG, Hunt PW, Martin JN, McCune JM. Seu L, et al. Among authors: ortiz gm. PLoS One. 2013 Dec 31;8(12):e84091. doi: 10.1371/journal.pone.0084091. eCollection 2013. PLoS One. 2013. PMID: 24391889 Free PMC article.

6

Levels of circulating myeloid subpopulations and of heme oxygenase-1 do not predict CD4(+) T cell recovery after the initiation of antiretroviral therapy for HIV disease.

Seu L, Ortiz GM, Burt TD, Deeks SG, Martin JN, McCune JM. Seu L, et al. Among authors: ortiz gm. AIDS Res Ther. 2014 Aug 5;11:27. doi: 10.1186/1742-6405-11-27. eCollection 2014. AIDS Res Ther. 2014. PMID: 25180041 Free PMC article.

7

Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects.

Ortiz GM, Wellons M, Brancato J, Vo HT, Zinn RL, Clarkson DE, Van Loon K, Bonhoeffer S, Miralles GD, Montefiori D, Bartlett JA, Nixon DF. Ortiz GM, et al. Proc Natl Acad Sci U S A. 2001 Nov 6;98(23):13288-93. doi: 10.1073/pnas.221452198. Epub 2001 Oct 30. Proc Natl Acad Sci U S A. 2001. PMID: 11687611 Free PMC article. Clinical Trial.

8

The relationship between T cell proliferative responses and plasma viremia during treatment of human immunodeficiency virus type 1 infection with combination antiretroviral therapy.

Binley JM, Schiller DS, Ortiz GM, Hurley A, Nixon DF, Markowitz MM, Moore JP. Binley JM, et al. Among authors: ortiz gm. J Infect Dis. 2000 Apr;181(4):1249-63. doi: 10.1086/315379. Epub 2000 Apr 13. J Infect Dis. 2000. PMID: 10762561

9

Risks and benefits of structured antiretroviral drug therapy interruptions in HIV-1 infection.

Bonhoeffer S, Rembiszewski M, Ortiz GM, Nixon DF. Bonhoeffer S, et al. Among authors: ortiz gm. AIDS. 2000 Oct 20;14(15):2313-22. doi: 10.1097/00002030-200010200-00012. AIDS. 2000. PMID: 11089619

10

Relevance of HIV-1-specific CD4+ helper T-cell responses during structured treatment interruptions in patients with CD4+ T-cell nadir above 400/mm3.

Plana M, Garcia F, Oxenius A, Ortiz GM, Lopez A, Cruceta A, Mestre G, Fumero E, Fagard C, Sambeat MA, Segura F, Miró JM, Arnedo M, Lopalcos L, Pumarola T, Hirschel B, Phillips RE, Nixon DF, Gallart T, Gatell JM. Plana M, et al. Among authors: ortiz gm. J Acquir Immune Defic Syndr. 2004 Jul 1;36(3):791-9. doi: 10.1097/00126334-200407010-00005. J Acquir Immune Defic Syndr. 2004. PMID: 15213562

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters